Skip to content

A study to assess the effect of Ayurvedic treatment in patients with acne (pimples)

A Comparative Clinical Study To Evaluate The Efficacy Of Lodhradi Lepa And Arjunatwaka Lepa In The Management Of Mukhadushika W.S.R To Acne Vulgaris - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/06/112932
Enrollment
40
Registered
2026-06-17
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil

Sponsors

SVM AYURVEDIC MEDICAL COLLEGE AND P.G RESEARCH CENTRE , ILKAL , KARNATAKA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1] patients having signs and symptoms of mukhadushika 2] age group of 16 to 40 years old 3] irrespective of gender , caste , religion and socio economic status 4] acne affecting the face 5]those who will give written inform consent

Exclusion criteria

Exclusion criteria: 1] drug induced acne i.e patient receiving systemic steriods , harmonal therapies or antibiotics 2] patient having local wound or infection 3] patient having nodular or cystic acne 4] history of allergic reaction to external application 5] patient with systemic and endocrine disorders

Design outcomes

Primary

MeasureTime frame
Reduction in acne severity assessed by total lesion countafter treatment with Lodhradi Lepa and Arjuntwaka Lepa.Timepoint: Baseline (Day 0) End of treatment (Day 30)

Secondary

MeasureTime frame
Reduction in inflammatory lesionsTimepoint: Baseline (Day 0) Day 30 (end of treatment) Day 60 (30-day follow-up)

Countries

India

Contacts

Public ContactSanket Milind Patel

SVM AYURVEDIC MEDICAL COLLEGE AND P.G RESEARCH CENTRE , ILKAL , KARNATAKA

vaidyaprasangjoshi@gmail.com9886313884

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026